Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for CVS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -2.693B
March 31, 2026 -2.318B
December 31, 2025 -2.032B
September 30, 2025 -1.382B
June 30, 2025 806.00M
March 31, 2025 -2.332B
December 31, 2024 431.00M
September 30, 2024 -1.588B
June 30, 2024 1.249B
March 31, 2024 -1.227B
December 31, 2023 -972.00M
September 30, 2023 -2.697B
June 30, 2023 3.626B
March 31, 2023 2.726B
December 31, 2022 -2.187B
September 30, 2022 -3.218B
June 30, 2022 -2.461B
March 31, 2022 -2.65B
December 31, 2021 -2.831B
September 30, 2021 -1.967B
June 30, 2021 -3.314B
March 31, 2021 -3.244B
December 31, 2020 -3.735B
September 30, 2020 -6.117B
June 30, 2020 -978.00M
Date Value
March 31, 2020 2.675B
December 31, 2019 -1.44B
September 30, 2019 -2.968B
June 30, 2019 -4.258B
March 31, 2019 816.00M
December 31, 2018 1.892B
September 30, 2018 -2.693B
June 30, 2018 -520.00M
March 31, 2018 38.14B
December 31, 2017 670.00M
September 30, 2017 -1.786B
June 30, 2017 -1.502B
March 31, 2017 -4.133B
December 31, 2016 -121.00M
September 30, 2016 -2.442B
June 30, 2016 -1.666B
March 31, 2016 -2.421B
December 31, 2015 -1.57B
September 30, 2015 9.743B
June 30, 2015 -761.00M
March 31, 2015 -2.406B
December 31, 2014 -1.561B
September 30, 2014 -1.775B
June 30, 2014 -1.423B
March 31, 2014 -935.00M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
The Cigna Group 207.00M
Centene Corp. -259.00M
Humana, Inc. 249.00M
Molina Healthcare, Inc. -4.00M
UnitedHealth Group, Inc. -8.623B